The SADRA Lotus Valve System: A fully repositionable, retrievable prosthesis

Minerva Cardioangiologica

Volumn 61, Issue 1, 2013, Pages 45-52

  Gooley, R ^a   Lockwood, S ^a   Antonis, P ^a   Meredith, I T ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Aortic valve; Aortic valve stenosis; Heart valve prosthesis implantation

Indexed keywords

AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTIFICIAL EMBOLISM; CEREBROVASCULAR ACCIDENT; DEVICE THERAPY; HUMAN; MEDICAL DEVICE COMPLICATION; POSTOPERATIVE HEMORRHAGE; REVIEW; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

HEART VALVE PROSTHESIS; HUMANS; PROSTHESIS DESIGN;

EID: 84876273868     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR et al. Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med 2012;366:1686-95.
2. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS et al. Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis. NEJM 2012;366:1696-704.
3. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P et al. Decision-making in Elderly Patients With Severe Aortic Stenosis: Why Are So Many Denied Surgery? Eur Heart J 2005;26:2714-20.
4. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.
5. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
6. Lange R, Bleiziffer S, Mazzitelli D, Elhmidi Y, Opitz A, Krane M et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J Am Coll Cardiol 2012;59:280-7.
7. Gilard M. French Aortic National Core Valve and Edwards Registry 2: FRANCE2. ESC 2011, Paris.
8. Linke A. ADVANCE CoreValve Registry 6-Month Data. ACC 2012 Scientific Sessions.
9. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcathter aortic valve implantation. J Am Coll Cardiol 2012;60:493-501.
10. Ghanem A, Muller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C et al. Risk and Fate of Cerebral Embolism After Transfemoral Aortic Valve Implantation. A prospective Pilot Study With Diffusion-Weighted Magnetic Resonance Imaging. J Am Coll Cardiol 2010;55:1427-32.
11. Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve intervention registry. Heart 2011;97:899-906.
12. Piazza N, de J egere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Intervent 2008;1:74-81.
13. Willson A, Webb J, LaBounty T, Achenbach S, Moss R, Wheeler M et al. 3-Dimensional Aortic Annular Assessment by Multidetector Computed Tomography Predicts Moderate or Severe Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: A Multicenter Retrospective Analysis. J Am Coll Cardiol 2012;59:1287-94.
14. Jilaihawi H, Kashif M, Fontana G, Furugen A, Shiota T, Friede G et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 2012;59:1275-86.
15. Mohammad A, Mohamed A, Björn S. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the medtronic corevalve bioprosthesis. J Am Coll Cardiol 2010;56:1623-9.
16. Webb J, Wood D. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol 2012;60:483-92.
17. Meredith I. Repositionable percutaneous replacement of a stenotic aortic valve through implantation of the Lotus Valve System: Discharge/7-Day Outcomes in the REPRISE I Study. Paris Course on Revascularization. Paris, France; 2012.
18. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011;57:253-69.